| |
|
|
|
|
|
|
|||
|
Blood, 1 July 2005, Vol. 106, No. 1, pp. 158-166. Prepublished online as a Blood First Edition Paper on March 8, 2005; DOI 10.1182/blood-2004-08-3232.
IMMUNOBIOLOGY A potential role for hydrocortisone in the positive regulation of IL-15activated NK-cell proliferation and survivalFrom the Cancer Immunology and Immunotherapy Center, Saint Savas Hospital, Athens, Greece.
Although glucocorticoids (GCs) have been described as acting mainly as anti-inflammatory and immunosuppressive drugs, they may also positively influence the immune system. In the present study, we demonstrate for the first time that hydrocortisone (HC), in synergy with interleukin-15 (IL-15), induces a dramatic increase in the expansion of peripheral bloodderived CD56+ cells, favoring the preferential outgrowth of classical natural killer (CD56+CD3 NK) over CD56+CD3+ natural killer T (NKT) cells. HC plus IL-15driven CD56+ cells exhibited an increased potential for cytokine production with no impairment in their NK- and lymphokine-activated killer (LAK) activities. Elevated levels of GC-induced leucine zipper protein (GILZ) messenger RNA (mRNA) were detected in both NK and NKT cells cultured with HC and IL-15, in comparison to IL-15 alone. Phosphorylation status of signal transducer and activator of transcription 5 (STAT5) was not affected by the presence of HC in either of the populations. On the contrary, HC differentially affected the IL-2/IL-15R
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||